BIOCRYST PHARMACEUTICALS, INC. (BCRX)

SEC filing

BIOCRYST PHARMACEUTICALS, INC.

BCRX · CIK 882796

4 · Mar 3, 2026 · Stonehouse Jon P exercised options for 306.00K shares; was granted 421 shares at $8.75/share ($3,684); reported 306.00K shares

Stonehouse Jon P exercised options for 306.00K shares; was granted 421 shares at $8.75/share ($3,684); reported 306.00K shares

PRIMARY DOCUMENT

xslF345X05/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).